These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 27905340)

  • 1. Effect of prophylactic intraocular pressure-lowering medication (brinzolamide) on intraocular pressure after ranibizumab intravitreal injection: A case-control study.
    Song S; Yu XB; Dai H
    Indian J Ophthalmol; 2016 Oct; 64(10):762-766. PubMed ID: 27905340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Dorzolamide/Timolol or Brinzolamide/Timolol prophylaxis on intravitreal anti-VEGF injection-induced intraocular hypertension.
    Kim GN; Han YS; Chung IY; Seo SW; Park JM; Yoo JM
    Semin Ophthalmol; 2013 Mar; 28(2):61-7. PubMed ID: 23448557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of prophylactic intraocular pressure-lowering medication on intraocular pressure spikes after intravitreal injections.
    Frenkel MP; Haji SA; Frenkel RE
    Arch Ophthalmol; 2010 Dec; 128(12):1523-7. PubMed ID: 21149773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monitoring intraocular pressure changes after intravitreal Ranibizumab injection using rebound tonometry.
    Fuest M; Kotliar K; Walter P; Plange N
    Ophthalmic Physiol Opt; 2014 Jul; 34(4):438-44. PubMed ID: 24731161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Efficacy of prophylactic treatment of intraocular pressure spikes due to intravitreal injections].
    El Chehab H; Le Corre A; Giraud JM; Ract-Madoux G; Swalduz B; Dot C
    J Fr Ophtalmol; 2012 Oct; 35(8):614-21. PubMed ID: 22832030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Topical application of hypotensive drugs for the prevention of intraocular pressure elevation after intravitreal injections of anti-VEGF drugs].
    Andreeva YS; Alkharki L; Shelankova AV; Budzinskaya MV
    Vestn Oftalmol; 2024; 140(2. Vyp. 2):73-79. PubMed ID: 38739134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of prophylactic medication and influence of vitreous reflux in pressure rise after intravitreal injections of anti-VEGF drugs.
    Carnota-Méndez P; Méndez-Vázquez C; Otero-Villar J; Saavedra-Pazos JA
    Eur J Ophthalmol; 2014; 24(5):771-7. PubMed ID: 24706353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medical control of intraocular pressure with brinzolamide 1% after phacoemulsification.
    Kir E; Cakmak H; Dayanir V
    Can J Ophthalmol; 2008 Oct; 43(5):559-62. PubMed ID: 18982032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-term changes of intraocular pressure and ocular perfusion pressure after intravitreal injection of bevacizumab or ranibizumab.
    Lee JW; Park H; Choi JH; Lee HJ; Moon SW; Kang JH; Kim YG
    BMC Ophthalmol; 2016 May; 16():69. PubMed ID: 27245159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of topical pressure-lowering medication on prevention of intraocular pressure spikes after intravitreal injection.
    El Chehab H; Le Corre A; Agard E; Ract-Madoux G; Coste O; Dot C
    Eur J Ophthalmol; 2013; 23(3):277-83. PubMed ID: 23161177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Topical Hypotensive Medications for Preventing Intraocular Pressure Increase after Cataract Surgery in Eyes with Glaucoma.
    Hayashi K; Yoshida M; Sato T; Manabe SI
    Am J Ophthalmol; 2019 Sep; 205():91-98. PubMed ID: 30902694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-term intraocular pressure trends following intravitreal ranibizumab injections for neovascular age-related macular degeneration-the role of oral acetazolamide in protecting glaucoma patients.
    Murray CD; Wood D; Allgar V; Walters G; Gale RP
    Eye (Lond); 2014 Oct; 28(10):1218-22. PubMed ID: 25081290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of topical brinzolamide 1% and brimonidine 0.2% on intraocular pressure after phacoemulsification.
    Cetinkaya A; Akman A; Akova YA
    J Cataract Refract Surg; 2004 Aug; 30(8):1736-41. PubMed ID: 15313300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prophylactic effect of brinzolamide-brimonidine fixed combination on intraocular pressure spikes after intravitreal anti-VEGF injections.
    Dettoraki M; Rapti E; Fragkos D; Theiopoulos I; Legaki A; Gkounta A; Anyfantaki D; Riga F
    Int Ophthalmol; 2021 Sep; 41(9):3191-3198. PubMed ID: 34114138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraocular pressure-lowering efficacy of brinzolamide 1%/timolol 0.5% fixed combination compared with brinzolamide 1% and timolol 0.5%.
    Kaback M; Scoper SV; Arzeno G; James JE; Hua SY; Salem C; Dickerson JE; Landry TA; Bergamini MV;
    Ophthalmology; 2008 Oct; 115(10):1728-34, 1734.e1-2. PubMed ID: 18538406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EFFECT OF SERIAL ANTERIOR CHAMBER PARACENTESIS ON SUSTAINED INTRAOCULAR PRESSURE ELEVATION IN PATIENTS RECEIVING INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY.
    Sisk RA; Rusia D; Zamora BG; Kuley A; Toussaint BW
    Retina; 2019 Oct; 39(10):1959-1964. PubMed ID: 30234855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Effect of Dorzolamide-timolol Eye drop on Intraocular Pressure Change in Intravitreal Ranibizumab Injected Patients.
    Coşkun M
    Middle East Afr J Ophthalmol; 2023; 30(2):85-88. PubMed ID: 39006931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraocular pressure changes related to intravitreal injections of ranibizumab: analysis of pseudophakia and glaucoma subgroup.
    Demirel S; Yanik O; Batioglu F; Ozmert E
    Int Ophthalmol; 2015 Aug; 35(4):541-7. PubMed ID: 25079762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sustained intraocular pressure elevation in eyes treated with intravitreal injections of anti-vascular endothelial growth factor for diabetic macular edema in a real-life setting.
    Vo Kim S; Fajnkuchen F; Sarda V; Qu-Knafo L; Bodaghi B; Giocanti-Aurégan A
    Graefes Arch Clin Exp Ophthalmol; 2017 Nov; 255(11):2165-2171. PubMed ID: 28831613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraocular Pressure Changes in Non-Glaucomatous Patients Receiving Intravitreal Anti-Vascular Endothelial Growth Factor Agents.
    Kiddee W; Montriwet M
    PLoS One; 2015; 10(9):e0137833. PubMed ID: 26360382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.